Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.

Market Analysis and Insights: Global Anti-Neoplastic Pharmaceutical Agents Market

The global Anti-Neoplastic Pharmaceutical Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Anti-Neoplastic Pharmaceutical Agents market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Anti-Neoplastic Pharmaceutical Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-Neoplastic Pharmaceutical Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Neoplastic Pharmaceutical Agents revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-Neoplastic Pharmaceutical Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anti-Neoplastic Pharmaceutical Agents revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Anti-Neoplastic Pharmaceutical Agents Market Report

Report Metric	Details
Report Name	Anti-Neoplastic Pharmaceutical Agents Market
CAGR	5%
Segment by Type	Hormones and Antagonists Microorganism Products Plant Products Antitumor Antibiotics Alkylating Agents Antimetabolites Natural Products
Segment by Application	Lung Cancer Bladder Cancer Breast Cancer Cervical Cancer Leukemia Gynecological Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol-Myers Squibb Company, Becton, Dickinson and Company, Pfizer Inc., Novartis AG, AstraZeneca, Gilead
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anti-Neoplastic Pharmaceutical Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Neoplastic Pharmaceutical Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Neoplastic Pharmaceutical Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Anti-Neoplastic Pharmaceutical Agents Market report?

Ans: The main players in the Anti-Neoplastic Pharmaceutical Agents Market are GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol-Myers Squibb Company, Becton, Dickinson and Company, Pfizer Inc., Novartis AG, AstraZeneca, Gilead

What are the Application segmentation covered in the Anti-Neoplastic Pharmaceutical Agents Market report?

Ans: The Applications covered in the Anti-Neoplastic Pharmaceutical Agents Market report are Lung Cancer, Bladder Cancer, Breast Cancer, Cervical Cancer, Leukemia, Gynecological Cancer, Other

What are the Type segmentation covered in the Anti-Neoplastic Pharmaceutical Agents Market report?

Ans: The Types covered in the Anti-Neoplastic Pharmaceutical Agents Market report are Hormones and Antagonists, Microorganism Products, Plant Products, Antitumor Antibiotics, Alkylating Agents, Antimetabolites, Natural Products

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Hormones and Antagonists

1.2.3 Microorganism Products

1.2.4 Plant Products

1.2.5 Antitumor Antibiotics

1.2.6 Alkylating Agents

1.2.7 Antimetabolites

1.2.8 Natural Products

1.3 Market by Application

1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Lung Cancer

1.3.3 Bladder Cancer

1.3.4 Breast Cancer

1.3.5 Cervical Cancer

1.3.6 Leukemia

1.3.7 Gynecological Cancer

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Perspective (2019-2030)

2.2 Global Anti-Neoplastic Pharmaceutical Agents Growth Trends by Region

2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Region (2019-2024)

2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Region (2025-2030)

2.3 Anti-Neoplastic Pharmaceutical Agents Market Dynamics

2.3.1 Anti-Neoplastic Pharmaceutical Agents Industry Trends

2.3.2 Anti-Neoplastic Pharmaceutical Agents Market Drivers

2.3.3 Anti-Neoplastic Pharmaceutical Agents Market Challenges

2.3.4 Anti-Neoplastic Pharmaceutical Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Anti-Neoplastic Pharmaceutical Agents by Players

3.1.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2019-2024)

3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2019-2024)

3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio

3.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2023

3.5 Global Key Players of Anti-Neoplastic Pharmaceutical Agents Head office and Area Served

3.6 Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Product and Application

3.7 Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Type

4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2019-2024)

4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2025-2030)

5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application

5.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Application (2019-2024)

5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)

6.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type

6.2.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024)

6.2.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030)

6.2.3 North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application

6.3.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024)

6.3.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030)

6.3.3 North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country

6.4.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)

6.4.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)

7.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type

7.2.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024)

7.2.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030)

7.2.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application

7.3.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024)

7.3.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030)

7.3.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country

7.4.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)

7.4.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)

8.2 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type

8.2.1 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024)

8.2.2 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030)

8.2.3 China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

8.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application

8.3.1 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024)

8.3.2 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030)

8.3.3 China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)

9.2 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type

9.2.1 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024)

9.2.2 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030)

9.2.3 Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

9.3 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application

9.3.1 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024)

9.3.2 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030)

9.3.3 Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

9.4 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region

9.4.1 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2019-2024)

9.4.3 Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type

10.2.1 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application

10.3.1 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country

10.4.1 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GlaxoSmithKline plc.

11.1.1 GlaxoSmithKline plc. Company Details

11.1.2 GlaxoSmithKline plc. Business Overview

11.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction

11.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.1.5 GlaxoSmithKline plc. Recent Developments

11.2 F. Hoffmann-La Roche Ltd

11.2.1 F. Hoffmann-La Roche Ltd Company Details

11.2.2 F. Hoffmann-La Roche Ltd Business Overview

11.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction

11.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.2.5 F. Hoffmann-La Roche Ltd Recent Developments

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Details

11.3.2 Eli Lilly and Company Business Overview

11.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction

11.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.3.5 Eli Lilly and Company Recent Developments

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.4.5 Bristol-Myers Squibb Company Recent Developments

11.5 Becton, Dickinson and Company

11.5.1 Becton, Dickinson and Company Company Details

11.5.2 Becton, Dickinson and Company Business Overview

11.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction

11.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.5.5 Becton, Dickinson and Company Recent Developments

11.6 Pfizer Inc.

11.6.1 Pfizer Inc. Company Details

11.6.2 Pfizer Inc. Business Overview

11.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction

11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.6.5 Pfizer Inc. Recent Developments

11.7 Novartis AG

11.7.1 Novartis AG Company Details

11.7.2 Novartis AG Business Overview

11.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction

11.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.7.5 Novartis AG Recent Developments

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction

11.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.8.5 AstraZeneca Recent Developments

11.9 Gilead

11.9.1 Gilead Company Details

11.9.2 Gilead Business Overview

11.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction

11.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

11.9.5 Gilead Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GlaxoSmithKline PLC

F Hoffmann La Roche Ltd

Eli Lilly and Company

Bristol Myers Squibb Company

Becton Dickinson and Company

List of Tables

Table 1. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Hormones and Antagonists

Table 3. Key Players of Microorganism Products

Table 4. Key Players of Plant Products

Table 5. Key Players of Antitumor Antibiotics

Table 6. Key Players of Alkylating Agents

Table 7. Key Players of Antimetabolites

Table 8. Key Players of Natural Products

Table 9. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 10. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Region (2019-2024)

Table 13. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Region (2025-2030)

Table 15. Anti-Neoplastic Pharmaceutical Agents Market Trends

Table 16. Anti-Neoplastic Pharmaceutical Agents Market Drivers

Table 17. Anti-Neoplastic Pharmaceutical Agents Market Challenges

Table 18. Anti-Neoplastic Pharmaceutical Agents Market Restraints

Table 19. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Players (2019-2024)

Table 21. Global Top Anti-Neoplastic Pharmaceutical Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2023)

Table 22. Global Anti-Neoplastic Pharmaceutical Agents Industry Ranking 2022 VS 2023 VS 2024

Table 23. Global 5 Largest Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue (CR5 and HHI) & (2019-2024)

Table 24. Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Headquarters and Area Served

Table 25. Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Product and Application

Table 26. Global Key Players of Anti-Neoplastic Pharmaceutical Agents, Product and Application

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2019-2024)

Table 30. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2025-2030)

Table 32. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Application (2019-2024)

Table 34. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Application (2025-2030)

Table 36. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 37. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030) & (US$ Million)

Table 38. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 39. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030) & (US$ Million)

Table 40. North America Anti-Neoplastic Pharmaceutical Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024) & (US$ Million)

Table 42. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030) & (US$ Million)

Table 43. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 44. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030) & (US$ Million)

Table 45. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 46. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030) & (US$ Million)

Table 47. Europe Anti-Neoplastic Pharmaceutical Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024) & (US$ Million)

Table 49. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030) & (US$ Million)

Table 50. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 51. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030) & (US$ Million)

Table 52. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 53. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 55. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030) & (US$ Million)

Table 56. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 57. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030) & (US$ Million)

Table 58. Asia Anti-Neoplastic Pharmaceutical Agents Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 59. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2019-2024) & (US$ Million)

Table 60. Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2025-2030) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 66. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024) & (US$ Million)

Table 67. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030) & (US$ Million)

Table 68. GlaxoSmithKline plc. Company Details

Table 69. GlaxoSmithKline plc. Business Overview

Table 70. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Product

Table 71. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 72. GlaxoSmithKline plc. Recent Developments

Table 73. F. Hoffmann-La Roche Ltd Company Details

Table 74. F. Hoffmann-La Roche Ltd Business Overview

Table 75. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Product

Table 76. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 77. F. Hoffmann-La Roche Ltd Recent Developments

Table 78. Eli Lilly and Company Company Details

Table 79. Eli Lilly and Company Business Overview

Table 80. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Product

Table 81. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 82. Eli Lilly and Company Recent Developments

Table 83. Bristol-Myers Squibb Company Company Details

Table 84. Bristol-Myers Squibb Company Business Overview

Table 85. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Product

Table 86. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 87. Bristol-Myers Squibb Company Recent Developments

Table 88. Becton, Dickinson and Company Company Details

Table 89. Becton, Dickinson and Company Business Overview

Table 90. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Product

Table 91. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 92. Becton, Dickinson and Company Recent Developments

Table 93. Pfizer Inc. Company Details

Table 94. Pfizer Inc. Business Overview

Table 95. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Product

Table 96. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 97. Pfizer Inc. Recent Developments

Table 98. Novartis AG Company Details

Table 99. Novartis AG Business Overview

Table 100. Novartis AG Anti-Neoplastic Pharmaceutical Agents Product

Table 101. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 102. Novartis AG Recent Developments

Table 103. AstraZeneca Company Details

Table 104. AstraZeneca Business Overview

Table 105. AstraZeneca Anti-Neoplastic Pharmaceutical Agents Product

Table 106. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 107. AstraZeneca Recent Developments

Table 108. Gilead Company Details

Table 109. Gilead Business Overview

Table 110. Gilead Anti-Neoplastic Pharmaceutical Agents Product

Table 111. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024) & (US$ Million)

Table 112. Gilead Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2023 VS 2030

Figure 3. Hormones and Antagonists Features

Figure 4. Microorganism Products Features

Figure 5. Plant Products Features

Figure 6. Antitumor Antibiotics Features

Figure 7. Alkylating Agents Features

Figure 8. Antimetabolites Features

Figure 9. Natural Products Features

Figure 10. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2023 VS 2030

Figure 12. Lung Cancer Case Studies

Figure 13. Bladder Cancer Case Studies

Figure 14. Breast Cancer Case Studies

Figure 15. Cervical Cancer Case Studies

Figure 16. Leukemia Case Studies

Figure 17. Gynecological Cancer Case Studies

Figure 18. Other Case Studies

Figure 19. Anti-Neoplastic Pharmaceutical Agents Report Years Considered

Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 21. Global Anti-Neoplastic Pharmaceutical Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Region: 2023 VS 2030

Figure 23. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2023

Figure 24. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2023)

Figure 25. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2023

Figure 26. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

Figure 28. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

Figure 29. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2019-2030)

Figure 30. United States Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Canada Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 33. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

Figure 34. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

Figure 35. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2019-2030)

Figure 36. Germany Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. France Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. U.K. Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Italy Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Russia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Nordic Countries Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 43. China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

Figure 44. China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

Figure 45. Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 46. Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

Figure 47. Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

Figure 48. Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Region (2019-2030)

Figure 49. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. South Korea Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. China Taiwan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Australia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 56. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2019-2030)

Figure 57. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2019-2030)

Figure 58. Middle East, Africa, and Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2019-2030)

Figure 59. Brazil Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Mexico Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Turkey Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 63. Israel Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 64. GCC Countries Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 65. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 66. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 67. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 69. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 70. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 71. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 72. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 73. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions